In a recent review, we claimed the identification and the characterization of a completely new atypical opioid receptor with exclusive adverse regulatory Houses in direction of opioid peptides.1 Our success showed that ACKR3/CXCR7, hitherto referred to as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is likewise a https://fredy171chi7.wikiparticularization.com/user